893
Views
13
CrossRef citations to date
0
Altmetric
Articles

Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review

, &

References

  • Abad, A. N. A., Nouri, M. H. K., Gharjanie, A., and Tavakoli, F. (2011a). Effect of matricaria chamomilla hydroalcoholic extract on cisplatin-induced neuropathy in mice. Chinese J. Nat. Med. 9(2):126–131.
  • Abad, A. N. A., Nouri, M. H. K, and Tavakkolia, F. (2011b). Effect of salvia officinalis hydroalcoholic extract on vincristine-induced neuropathy in mice. Chin J. Nat. Med. 9(5):354–358.
  • Ahlemeyer, B. and Krieglstein, J. (2003). Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry. 36(1):8–14.
  • Al Moundhri, M. S., Al-Salam, S., Al Mahrouqee, A., Beegam, S., and Ali, B. H. (2013). The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies. J. Med. Toxicol. 9(1):25–33.
  • Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., and Kalofonos, H. P. (2005). Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial. Neurology. 64(1):26–31.
  • Argyriou, A. A., Chroni, E., Koutras, A., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., and Kalofonos, H. P. (2006). A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer. 14(11):1134–1140.
  • Argyriou, A. A., and Kalofonos, H. P. (2011). Vitamin E for preventing chemotherapy-induced peripheral neuropathy. Support Care Cancer. 19(5):725–726.
  • Armstrong, T., Almadrones, L., and Gilbert, M. R. (2005). Chemotherapy-induced peripheral neuropathy. Oncol. Nurs. Forum. 32(2):305–311.
  • Bahar, A. M., Andoh, T., Ogura, K., Hayakawa, Y., Saiki, I., and Kuraishi, Y. (2013). Herbal medicine goshajinkigan prevents paclitaxel-induced mechanical allodynia without impairing antitumor activity of paclitaxel. Evid. Based Compl. Alternative Medicine. Dx.doi.org/10.1155/2013/849754
  • Berry, M. (1995). The chamomiles. Pharma. J. 254:191–193.
  • Bhagra, A., and Rao, R. D. (2007). Chemotherapy-induced neuropathy. Curr. Oncol. Rep. 9(4):290–299.
  • Biesbroeck, R., Bril, V., Hollander, P., Kabadi, U., Schwartz, S., Singh, S. P., Ward, W. K., and Bernstein, J. E. (1995). A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv. Ther. 12(2):111–120.
  • Brown, S., Simpson, D. M., Moyle, G., Brew, B. J., Schifitto, G., Larbalestier, N., Orkin, C., Fisher, M., Vanhove, G. F., and Tobias, J. K. (2013). NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res. Ther. 10(1):5. Doi: 10.1186/1742-6405-10-5.
  • Cakil, B., Basar, F. S., Atmaca, S., Cengel, S. K., Tekat, A., and Tanyeri, Y. (2012). The protective effect of Ginkgo biloba extract against experimental cisplatin ototoxicity: animal research using distortion product otoacoustic emissions. J. Laryngol. Otol. 126(11):1097–1101.
  • Cavaletti, G., and Marmiroli, P. (2004). Chemotherapy-induced peripheral neurotoxicity. Expert. Opin. Drug. Saf. 3(6):535–546.
  • Cavaletti, G., Nicolini, G., and Marmiroli, P. (2008). Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. Front Biosci. 13:3506–3524.
  • Cavaletti, G., Alberti, P., Frigeni, B., Piatti, M., and Susani, E. (2011). Chemotherapy-induced neuropathy. Curr. Treat Opt. Neurol. 13(2):180–190.
  • Chad, D. A., Aronin, N., Lundstrom, R., McKeon, P., Ross, D., Molitch, M., Schipper, H. M., Stall, G., Dyess, E., and Tarsy, D. (1990). Does capsaicin relieve the pain of diabetic neuropathy? Pain. 42(3):387–388.
  • Choi, Y. C., Kwon, K. R., and Choi, S. H. (2006). Purification of peptide components including melittin from bee venom using gel filtration chromotography and propionic acid/urea polyacrylamide gel electrophoresis. J. Korean Pharmacoacupun. Inst. 9:105–112.
  • Clifford, D. B., Simpson, D. M., Brown, S., Moyle, G., Brew, B. J., Conway, B., Tobias, J. K., Vanhove, G. F.; NGX-4010 C119 Study Group. (2012). A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J. Acquir. Immune Defic. Syndr. 59(2):126–133.
  • Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E., Coory, M., Hatcher, J., McGahan, C. E., Turner, D., Marrett, L., Gjerstorff, M. L., Johannesen, T. B., Adolfsson, J., Lambe, M., Lawrence, G., Meechan, D., Morris, E. J., Middleton, R., Steward, J., Richards, M. A., and the and I.M.W. Group*. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership). (2011). An analysis of population-based cancer registry data. Lancet. 377(9760):127–138.
  • Deng, J. H., and Zou, S. L. (2007). Observation on TCM treatment of 32 cases of chemotherapy-induced peripheral neuropathy. J. Pract. Trad. Chin. Int. Med. 21:2.
  • Ferrier, J., Pereira, V., Busserolles, J., Authier, N., and Balayssac, D. (2013). Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr. Pain Headache Rep. 17(10):364.
  • Fujii, K., Okamoto, S., Saitoh, K., Sasaki, N., Takano, M., Tanaka, S., Kudoh, K., Kita, T., Tode, T., and Kikuchi, Y. (2004). The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma. Gan To Kagaku Ryoho. 31(10):1537–1540.
  • Ghoreishi, Z., E.A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Asghari Jafarabadi M, Montazeri, V., Keshavarz, S. A., and Darabi, M. (2012). Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomised double-blind placebo controlled trial. BMC Cancer. 12:355.
  • Hashimoto, K., Sakuma, Y., and Kotani, J. (2004). Histological study of a paclitaxel-induced peripheral neuropathy model treated with goshajinkigan. J. Osaka Dental Univ. 38(2):109–112.
  • Hashimoto, K., Sakuma, Y., and Kotani, J. (2006). Goshajinkigan improves paclitaxel-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. J. Osaka Dental Univ. 40(1):47–52.
  • Hidaka, T., Shima, T., Nagira, K., Ieki, M., Nakamura, T., Aono, Y., Kuraishi, Y., Arai, T., and Saito, S. (2009). Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice. Eur. J. Pain. 13(1):22–27.
  • Hosokawa, A., Ogawa, K., Ando, T., Suzuki, N., Ueda, A., Kajiura, S., Kobayashi, Y., Tsukioka, Y., Horikawa, N., Yabushita, K., Fukuoka, J., and Sugiyama, T. (2012). Preventative effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: A multicentre retrospective study. Ant. Res. 32(7):2545–2550.
  • Howes, M. J., Perry, N. S., and Houghton, P. J. (2003). Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res. 17(1):1–18.
  • Huang, X., Whitworth, C. A., and Rybak, L. P. (2007). Ginkgo biloba extract (Egb 761) protects against cisplatin-induced ototoxicity in rats. Otol. Neurotol. 28(6):828–833.
  • Japan Society of Oriental Medicine. (2005). Introduction of Kampo. Japanese Traditional Medicine. Elsevier, Tokyo, Japan.
  • Kaku, H., Kumagai, S., Onoue, H., Takada, A., Shoji, T., Miura, F., Yoshizaki, A., Sato, S., Kigawa, J., Arai, T., Tsunoda, S., Tominaga, E., Aoki, D., and Sugiyama, T. (2012). Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicentre collaborative study. Exp. Therapeut. Med. 3(1):60–65.
  • Kaley, T. J., and Deangelis, L. M. (2009). Therapy of chemotherapy-induced peripheral neuropathy. Br. J. Haematol. 145(1):3–14.
  • Kono, T., Mamiya, N., Chisato, N., Ebisawa, Y., Yamazaki, H., Watari, J., Yamamoto, Y., Suzuki, S., Asama, T., and Kamiya, K. (2011). Efficacy of Goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid. Based Complement. Alternat. Med. (418481):8.
  • Kono, T., Hata, T., Morita, S., Munemoto, Y., Matsui, T., Kojima, H., Takemoto, H., Fukunaga, M., Nagata, N., Shimada, M., Sakamoto, J., and Mishima, H. (2013). Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy. Cancer Chemother. Pharmacol. October 72(6):1283–1290.
  • Kwon, K. R., Choi, S. H., and Cha, B. C. (2006). Component analysis of sweet BV and clinical trial on antibody titer and allergic reactions. J. Korean Pharmacoacupun. Inst. 9:79–86.
  • Lee, J. S., Lee, J. Y., Kwon, K. R., and Lee, H. C. (2006). A study on allergic response between bee venom and sweet bee venom pharmacopuncture. J. Korean Pharmacoacupun. Inst. 9:61–77.
  • Li, H. J., Jiang, Y., and Li, P. (2006). Chemistry, bioactivity and geographical diversity of steroidal alkaloids from the Liliaceae family. Nat. Prod. Rep. 23(5):735–752.
  • Lim, B. S., Moon, H., Li, D. X., Gil, M., Min, J. K., Lee, G., Bae, H., Kim, S. K., and Min, B. I. (2013). Effect of Bee venom acupuncture on oxaliplatin-induced cold allodynia in rats. Evid. Based Complement. Alternat. Med. 2013:369324.
  • Low, P. A., Opfer-Gehrking, T. L., Dyck, P. J., Litchy, W. J., and O'Brien, P. C. (1995). Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain. 62(2):163–168.
  • Marshall, J., Zakari, A., Hwang, J. J., Papadopoulos, V., Rosenberg, A., Silver, C. (2004). Ginkgo Biloba (GB) extract as a neuroprotective agent in oxaliplatin (Ox)-induced neuropathy. American Society of Clinical Oncologists Annual Meeting Proceedings. J. Clin. Oncol. 22(14) abstract 3670
  • Mills, S. (1991). The Essential Book of Herbal Medicine. 2nd ed. Penguin Books Ltd., London
  • Muthuraman, A., Singh, N., and Jaggi, A. S. (2011). Protective effect of Acorus calamus L. in rat model of vincristine induced painful neuropathy: An evidence of anti-inflammatory and anti-oxidative activity. Food Chem. Toxicol. 49(10):2557–2563.
  • NHMRC. (2009). National Health and Medical Research Council. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Co., Australia.
  • Nishioka, M., Shimada, M., Kurita, N., Iwata, T., Morimoto, S., Yoshikawa, K., Higashijima, J., Miyatani, T., and Kono, T. (2011). The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int. J. Clin. Onc. 16(4):322–327.
  • No authors listed. (1991). Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Arch. Intern. Med. 151(11):2225–2229.
  • Oh, H., Kang, D. G., Lee, S., Lee, Y., and Lee, H. S. (2003). Angiotensin converting enzyme (ACE) inhibitory alkaloids from Fritillaria ussuriensis. Planta Med. 69(6):564–565.
  • Oztürk, G., Anlar, O., Erdoğan, E., Kösem, M., Ozbek, H., and Türker, A. (2004). The effect of Ginkgo extract Egb761 in cisplatin-induced peripheral neuropathy in mice. Toxicol. Appl. Pharmacol. 196(1):169–175.
  • Pace, A., Antonella, S., Mauro, P., Vittoria, M., Umberto, P., Girolamo Del, M., Annamaria, B., Carlo, L., Bruno, J., Francesco, C., and Loredana, B. (2003). Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. Source J. Clin. Oncol. 21(5):927–931.
  • Pace, A., Giannarelli, D., Galie, E., Savarese, A., Carpano, S., Della Giula, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., Jandolo, B., Bove, L., and Cognett, F. (2010). Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial. Neurology. 74(9):762–766.
  • Pan, L., Gao, H., and Xing, X. R. (2012). Combined application of traditional Chinese medicine prevention of taxol chemotherapy-induced peripheral neuropathy; a clinical observation. Neimenggu Zhong Yi Yao. 3:28.
  • Park, S. B., Krishnan, A. V., Lin, C. S. Y., Goldstein, D., Friedlander, M., and Kiernan, M. C. (2008). Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr. Med. Chem. 15(29):3081–3094.
  • Park, J. W., Jeon, J. H., Yoon, J. W., Jung, T. Y., Kwon, K. R., Cho, C. K., Lee, Y. W., Sagar, S., Wong, R., and Yoo, H. S. (2011). Effects of sweet be venom pharmacopuncture for chemotherapy-induced peripheral neuropathy. Integr. Cancer Ther. 11(2):166–171.
  • Pirzada, N. A., Ali, I. I., and Dafer, R. M. (2000) Fluorouracil-induced neurotoxicity. Ann. Pharmacother. 34(1):35–38.
  • Rahn, E. J., Makriyannis, A., and Hohmann, A. G. (2007). Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br. J. Pharmacol. 152(5):765–777
  • Rahn, E. J., Zvonok, A. M., Thakur, G. A., Khanolkar, A. D., Makriyannis, A., and Hohmann, A. G. (2008). Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. J. Pharmacol. Exp. Ther. 327(2):584–591.
  • Schiff, D., Wen, P. Y., and van den Bent, M. J. (2009). Neurological adverse effects caused by cytotoxic and targeted therapies. Nat. Rev. Clin. Oncol. 6(10):596–603.
  • Schloss, J. M., Colosimo, M., Airey, C., Masci, P. P., Linnane, A. W., and Vitetta, L. (2013). Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review. Clin. Nutr. 32(6):888–893
  • Schröder, S., Beckmann, K., Franconi, G., Meyer-Hamme, G., Friedemann, T., Greten, H. J., Rostock, M., and Efferth, T. (2013). Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evid. Based Complement. Alternat. Med. 2013:423713.
  • Shindo, Y., Tenma, K., Imano, H., Hibino, M., Yoshino, K., Nakamura, M. (2008). Reduction of oxaliplatin-related neurotoxicity by Gosha-jinki-gan. Gan Tto Kagaku Ryoho. 35(5):863–865.
  • Sima, L., Pan, L. (2009). Influence of Chinese herb on chemotherapy-induced peripheral neuropathy. Ann. Oncol. 20(3):iii45–iii46.
  • Simpson, D. M., Brown, S., Tobias, J. K., Vanhove, G. F. For the NGX-4010 C107 Study Group. (2013). NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: Results of a 52-week open-label study. Clin. J. Pain. 30(2):134–142.
  • Sindrup, S. H., Madsen, C., Bach, F. W., Gram, L. F., and Jensen, T. S. (2001). St. John's wort has no effect on pain in polyneuropathy. Pain. 91(3):361–365.
  • Smith, E. M., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., Gilman, P. B., Shapiro, C. L.; Alliance for Clinical Trials in Oncology. (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 309(13):1359–1367.
  • Sun, Y. Y., Jia, Y. J., Huang, M. N., and Chen, J. (2008). Buyang huanwu decoction in prevention of peripheral neuropathy after chemotherapy: A clinical observation. Guang. J. Chin. Med. 23(7):958–959.
  • Takenaka, M., Iida, H., Matsumoto, S., Yamaguchi, S., Yoshimura, N., and Miyamoto, M. (2014). Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel. Am. J. Hosp. Palliat. Care. 330(7):734–736.
  • Tandan, R., Lewis, G., Badger, G. B., and Fries, T. (1992). Topical capsaicin in painful diabetic neuropathy: Effect on sensory function. Diabet. Care. 15(1):15–18.
  • Tatsumi, T., Kishi, D., and Kogure, T. (2009). The efficacy of ogikeishigomotsuto on chronic cumulative sensory neuropathy induced by oxaliplatin—case report and literature view. J. Tradit. Med. 26(3):136–140.
  • Ushio, S., Egashira, N., Sada, H., Kawashiri, T., Shirahama, M., Masuguchi, K., and Oishi, R. (2012). Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur. J. Cancer. 48(9):1407–1413.
  • Visovsky, C., Meyer, R. R., Roller, J., and Poppas, M. (2008). Evaluation and management of peripheral neuropathy in diabetic patients with cancer. Clin. J. Oncol. Nurs. 12(2):243–247.
  • Wang, C. N., Chi, C. W., Lin, Y. L., Chen, C. F., and Shiao, Y. J. (2001). The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 276(7):5287–5295
  • Wang, Q. R. (2007). Yi Lin Gai Guo: Correcting the Errors in the Forest of Medicine. Blue Poppy Press, Boulder, Colo, USA.
  • Wolf, S., Barton, D., Kottschade, L., Grothey, A., and Loprinzi,  . (2008). Chemotherapy-induced Peripheral Neuropathy: prevention and treatment strategies. Eur. J. Cancer. 44(11):1507–1515
  • Xu, F., Xu, S., Wang, L., Chen, C., Zhou, X., Lu, Y., and Zhang, H. (2011). Antinociceptive efficacy of verticinone in murine models of inflammatory pain and paclitaxel induced neuropathic pain. Biol. Pharmaceut. Bull. 34(9):1377–1382.
  • Xu, O., Lu, H., Li, P. Q., Zhang, X., and Lu, Z. (2004). Effect of combination of Ginkgo leaf extract and deferoxamine in preventing and treating ototoxicity of cisplatin. Zhongguo Zhong Xi Yi Jie He Za Zhi. 24(10):915–918.
  • Yamada, T., Kan, H., Matsumoto, S., Koizumi, M., Sasaki, J., Tani, A., Yokoi, K., and Uchida, E. (2012). Reduction in oxaliplatin-related neurotoxicity by the administration of Keishikajutsubuto (TJ-18) and powdered processed aconite root. Gan To Kagaku Ryoho. 39(11):1687–1691.
  • Yamamoto, T., Murai, T., Ueda, M., Katsuura, M., Oishi, M., Miwa, Y., Okamoto, Y., Uejima, E., Taguchi, T., Noguchi, S., and Kurokawa, N. (2009). Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosyajinki-gan. Gan To Kagaku Ryoho. 36(1):89–92.
  • Yoon, J., Jeon, J. H., Lee, Y. W., Cho, C. K., Kwon, K. R., Shin, J. E., Sagar, S., Wong, R., and Yoo, H. S. (2012). Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy. J. Acupunct. Meridian. Stud. 5(4):156–165.
  • Zhou, Y., Ji, H., Lin, B. Q., Jiang, Y., and Li, P. (2006). The effects of five alkaloids from Bulbus Fritillariae on the concentration of cAMP in HEK cells transfected with muscarinic M(2) receptor plasmid. Am. J. Chin. Med. 34(5):901–910.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.